208 related articles for article (PubMed ID: 25887070)
1. Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View.
Fried LF; Lewis J
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1089-93. PubMed ID: 25887070
[TBL] [Abstract][Full Text] [Related]
2. Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View.
Lambers Heerspink HJ; Gansevoort RT
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1079-88. PubMed ID: 25887073
[TBL] [Abstract][Full Text] [Related]
3. A Population-Based Analysis of Quality Indicators in CKD.
Manns L; Scott-Douglas N; Tonelli M; Weaver R; Tam-Tham H; Chong C; Hemmelgarn B
Clin J Am Soc Nephrol; 2017 May; 12(5):727-733. PubMed ID: 28377473
[TBL] [Abstract][Full Text] [Related]
4. Rebuttal of the Pro View: Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD.
Fried LF; Lewis J
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1095-8. PubMed ID: 25887072
[No Abstract] [Full Text] [Related]
5. Rebuttal of the Con View: Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD.
Lambers Heerspink HJ; Gansevoort RT
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1099. PubMed ID: 25887066
[TBL] [Abstract][Full Text] [Related]
6. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
Ji E; Kim YS
Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
[TBL] [Abstract][Full Text] [Related]
8. Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).
Fried LF; Duckworth W; Zhang JH; O'Connor T; Brophy M; Emanuele N; Huang GD; McCullough PA; Palevsky PM; Seliger S; Warren SR; Peduzzi P;
Clin J Am Soc Nephrol; 2009 Feb; 4(2):361-8. PubMed ID: 19118120
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease.
Wu PC; Wu CJ; Lin CJ; Pan CF; Chen CY; Huang TM; Wu CH; Lin SL; Chen YM; Chen L; Wu VC; ;
Clin Pharmacol Ther; 2015 Oct; 98(4):442-9. PubMed ID: 26082272
[TBL] [Abstract][Full Text] [Related]
10. Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
Bakris GL; Kuritzky L
Postgrad Med; 2009 Jul; 121(4):51-60. PubMed ID: 19641270
[TBL] [Abstract][Full Text] [Related]
11. Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.
Abe M; Suzuki H; Okada K; Maruyama N; Inoshita A; Baba S; Takashima H; Soma M
Heart Vessels; 2013 Jul; 28(4):442-52. PubMed ID: 22618635
[TBL] [Abstract][Full Text] [Related]
12. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system blockade alone or combined with ET
Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
[TBL] [Abstract][Full Text] [Related]
14. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol.
Keyzer CA; de Jong MA; Fenna van Breda G; Vervloet MG; Laverman GD; Hemmelder M; Janssen WM; Lambers Heerspink HJ; Navis G; de Borst MH;
Nephrol Dial Transplant; 2016 Jul; 31(7):1081-7. PubMed ID: 25744274
[TBL] [Abstract][Full Text] [Related]
16. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
[TBL] [Abstract][Full Text] [Related]
17. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Jin SM; Han KA; Yu JM; Sohn TS; Choi SH; Chung CH; Park IeB; Rhee EJ; Baik SH; Park TS; Lee IK; Ko SH; Hwang YC; Cha BS; Lee HW; Nam MS; Lee MK
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2108-14. PubMed ID: 27493100
[TBL] [Abstract][Full Text] [Related]
18. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
[TBL] [Abstract][Full Text] [Related]
19. A perspective on chronic kidney disease progression.
Zhong J; Yang HC; Fogo AB
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F375-F384. PubMed ID: 27974318
[TBL] [Abstract][Full Text] [Related]
20. Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis.
Wong MG; Ninomiya T; Liyanage T; Sukkar L; Hirakawa Y; Wang Y; Wyld MLR; Morton RL; Chadban S; Howard K; Jardine MJ
Nephrology (Carlton); 2019 Jun; 24(6):605-614. PubMed ID: 30039893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
